Prokidney (PROK) Return on Capital Employed (2022 - 2026)
Prokidney's (PROK) quarterly Return on Capital Employed came in at 58.47% in Q1 2026, down 1113.0% year-on-year from 5.77% in Q1 2025, and down 10.87% on a QoQ basis from 52.74% in Q4 2025.
Prokidney (PROK) Return on Capital Employed (2022 - 2026) Analysis & Trends
Prokidney (PROK) has 5 years of Return on Capital Employed data on file, last reported at 58.47% in Q1 2026.
- On a quarterly basis, Return on Capital Employed fell 1113.0% year-over-year to 58.47% in Q1 2026; TTM through Mar 2026 was 58.47%, a 1113.0% decrease from a year earlier, with the FY2025 full-year figure at 46.15%, up 40.0% from the prior year.
- Return on Capital Employed for Q1 2026 stood at 58.47%, down from 52.74% in the prior quarter.
- Over the last five years, Return on Capital Employed for PROK reached as high as 25.73% in Q1 2023 and fell as low as 61.29% in Q1 2022.
- Historically, Return on Capital Employed has averaged 41.78% across 5 years, with a median of 39.16% in 2024.
- Across the five-year window, Return on Capital Employed jumped 3557 bps in 2023 and sank 1759 bps in 2025, its largest moves.
- Year by year, Return on Capital Employed stood at 29.75% in 2022, then fell by 24 bps to 36.85% in 2023, then fell by 18 bps to 43.55% in 2024, then retreated by 21 bps to 52.74% in 2025, then fell by 11 bps to 58.47% in 2026.
- Per Business Quant data, the three most recent Return on Capital Employed figures were 58.47% in Q1 2026, 52.74% in Q4 2025, and 51.44% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | -31.80% |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -107.40% |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 10.46% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 21.10% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 10.19% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | -68.84% |
| 10 | Prokidney | 96.00 Mn | 96.00 Mn | - | -58.47% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -58.47% |
| Dec 31, 2025 | -52.74% |
| Sep 30, 2025 | -51.44% |
| Jun 30, 2025 | -50.34% |
| Mar 31, 2025 | -47.34% |
| Dec 31, 2024 | -43.55% |
| Sep 30, 2024 | -33.85% |
| Jun 30, 2024 | -36.41% |
| Mar 31, 2024 | -39.16% |
| Dec 31, 2023 | -36.85% |
| Sep 30, 2023 | -35.24% |
| Jun 30, 2023 | -31.49% |
| Mar 31, 2023 | -25.73% |
| Dec 31, 2022 | -29.75% |
| Sep 30, 2022 | -32.76% |
| Jun 30, 2022 | -43.88% |
| Mar 31, 2022 | -61.29% |